- Home
- PLBC vs XGN Comparison
PLBC vs XGN Comparison
Compare PLBC & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- XGN
- Stock Information
- Founded
- PLBC 1980
- XGN 2002
- Country
- PLBC United States
- XGN United States
- Employees
- PLBC N/A
- XGN N/A
- Industry
- PLBC Finance Companies
- XGN Medical Specialities
- Sector
- PLBC Finance
- XGN Health Care
- Exchange
- PLBC Nasdaq
- XGN Nasdaq
- Market Cap
- PLBC 236.7M
- XGN 210.4M
- IPO Year
- PLBC 2005
- XGN 2019
- Fundamental
- Price
- PLBC $42.40
- XGN $10.88
- Analyst Decision
- PLBC Buy
- XGN Strong Buy
- Analyst Count
- PLBC 4
- XGN 5
- Target Price
- PLBC $57.00
- XGN $12.40
- AVG Volume (30 Days)
- PLBC 20.0K
- XGN 248.4K
- Earning Date
- PLBC 10-17-2025
- XGN 11-11-2025
- Dividend Yield
- PLBC 2.84%
- XGN N/A
- EPS Growth
- PLBC 1.22
- XGN N/A
- EPS
- PLBC 4.86
- XGN N/A
- Revenue
- PLBC $84,003,000.00
- XGN $58,862,000.00
- Revenue This Year
- PLBC $22.16
- XGN $22.28
- Revenue Next Year
- PLBC $17.58
- XGN $14.03
- P/E Ratio
- PLBC $8.70
- XGN N/A
- Revenue Growth
- PLBC 6.85
- XGN 3.89
- 52 Week Low
- PLBC $37.69
- XGN $2.38
- 52 Week High
- PLBC $51.33
- XGN $11.17
- Technical
- Relative Strength Index (RSI)
- PLBC 44.10
- XGN 63.84
- Support Level
- PLBC $41.50
- XGN $9.30
- Resistance Level
- PLBC $43.16
- XGN $11.11
- Average True Range (ATR)
- PLBC 0.90
- XGN 0.43
- MACD
- PLBC -0.20
- XGN 0.04
- Stochastic Oscillator
- PLBC 22.73
- XGN 84.17
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.